Ipca Laboratories Ltd. Financials

NSE BSE

15:56 Jul 18

Ipca Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1471.00

-3.10 (-0.21%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1471.00

-3.10 (-0.21%)
15:56 Jul 18

Quality

98/100
High Financial Strength

Valuation

39/100
Mid Valuation

Technical

51/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	5419.99	5829.79	6244.32	7705.04	8939.59
Operating Expenses +	3875.64	4520.53	5317.55	6383.88	7213.45
Raw Material	1923.09	2144.5	2205.84	2706.39	2824.6
Increase Decrease in Cost	-194.79	-129.65	100.67	-130.64	-46.05
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1013.57	1177.39	1287.64	1708.43	1983.99
Miscellaneous Expenses	1785.67	2288.89	2717.78	3079.84	3546.47
Operating Profit	1544.35	1309.26	926.77	1321.16	1726.14
Other Income	62.84	66.57	125.62	124.77	92.8
Depreciation	209.17	232.42	261.56	357.24	397.82
Interest	9.04	7.69	45.54	138.27	84.93
Profit before tax and exceptio..	1388.98	1135.72	745.29	950.42	1336.19
Exceptional Items	0	0	0	-107.75	-205.05
PBT	1388.98	1135.72	745.29	842.67	1131.14
Provision for Taxation	240.14	224.77	253.36	313.46	343.61
Net Profit	1148.84	910.95	491.93	529.21	787.53
NET Profit after MI	1140.01	884.08	471.32	547.35	737.68
EPS	45.01	34.85	18.58	21.57	35.14
Operating Profit Margin (%)	28.49	22.46	14.84	17.15	19.31
Net Profit Margin (%)	21.03	15.16	7.55	7.1	8.25

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	44.70	44.70	44.70	46.30	46.30
FII	10.70	10.80	11.10	10.80	10.80
MF	29.60	29.60	29.60	28.60	28.50
Others	6.60	6.40	6.00	5.60	5.30

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: